Mitochondria Are Direct Targets of the Lipoxygenase Inhibitor MK886: A STRATEGY FOR CELL KILLING BY COMBINED TREATMENT WITH MK886 AND CYCLOOXYGENASE INHIBITORS
Open Access
- 30 August 2002
- journal article
- Published by Elsevier
- Vol. 277 (35) , 31789-31795
- https://doi.org/10.1074/jbc.m204450200
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- Endonuclease G is an apoptotic DNase when released from mitochondriaNature, 2001
- Arachidonic Acid Causes Cell Death through the Mitochondrial Permeability TransitionJournal of Biological Chemistry, 2001
- A mitochondrial perspective on cell deathTrends in Biochemical Sciences, 2001
- Identification of DIABLO, a Mammalian Protein that Promotes Apoptosis by Binding to and Antagonizing IAP ProteinsCell, 2000
- Smac, a Mitochondrial Protein that Promotes Cytochrome c–Dependent Caspase Activation by Eliminating IAP InhibitionCell, 2000
- Mitochondrial Transport of Cations: Channels, Exchangers, and Permeability TransitionPhysiological Reviews, 1999
- Bcl-2 inhibits the mitochondrial release of an apoptogenic protease.The Journal of Experimental Medicine, 1996
- Induction of Apoptotic Program in Cell-Free Extracts: Requirement for dATP and Cytochrome cPublished by Elsevier ,1996
- Cyclooxygenase and lipoxygenase inhibitors in cancer therapyProstaglandins, Leukotrienes & Essential Fatty Acids, 1996
- On the involvement of a cyclosporin A sensitive mitochondrial pore in myocardial reperfusion injuryCardiovascular Research, 1993